These are mechanically computed values based on a residual income model. They are not a forecast of market prices or a recommendation of any investment action, and do not predict or guarantee future share prices. Historical values are computed retrospectively using current guidance-achievement statistics.
| Metric | Current Period | Same Period of Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥1523.8B | ¥1392.7B | +9.4% |
| Operating Income | ¥140.4B | ¥130.4B | +7.7% |
| Ordinary Income | ¥145.7B | ¥123.4B | +18.1% |
| Net Income | ¥95.5B | ¥99.2B | -3.8% |
| ROE | 2.5% | 2.7% | - |
Although revenue and profit increased at the operating and ordinary income levels, final profit declined slightly due to a higher tax burden and temporary losses. Revenue increased to ¥1523.8B (+9.4% YoY), Operating Income rose to ¥140.4B (+7.7%), and Ordinary Income grew to ¥145.7B (+18.1%), while Net Income attributable to owners of the parent remained at ¥93.6B (-2.7%). The main driver of higher revenue was substantial growth in High Performance Polymers (+23.9%), while growth in Ordinary Income was supported by increased equity-method investment income and lower non-operating expenses. The decline in final profit was primarily attributable to the higher income tax burden (effective tax rate: 33.9%) and a ¥2.7B loss on disposal of fixed assets.
【Revenue】Revenue of ¥1523.8B (+9.4%) increased in five of the six segments, with High Performance Polymers, the largest segment, serving as the primary driver of company-wide growth at ¥642.3B (+23.9%). Materials declined slightly to ¥502.9B (-2.3%), while Safety at ¥264.9B (+8.2%), Smart at ¥107.8B (+13.7%), and Life Sciences at ¥49.5B (+15.9%) broadened the growth base with increases approaching double digits.
【Profit and Loss】Operating Income was ¥140.4B (+7.7%), with the 9.2% Operating Income margin reflecting a partial offset to the decline in the gross margin to 27.4% (down 1.3pt from 28.7% in the previous year) through the containment of the SG&A expense ratio at 18.2%. Ordinary Income grew faster than Operating Income, increasing to ¥145.7B (+18.1%), supported by the recognition of ¥8.8B in equity-method investment income and improvements in non-operating items, including a reduction in foreign exchange losses. Net special gains and losses amounted to -¥1.2B, consisting of a ¥1.5B gain on the sale of investment securities and a ¥2.7B loss on disposal of fixed assets, and had a limited impact. However, after deducting income taxes of ¥49.1B (effective tax rate: 33.9%) and Net Income attributable to non-controlling interests of ¥1.9B, Net Income attributable to owners of the parent was ¥93.6B (-2.7%). The results present a dual aspect: revenue and profit growth at the operating and ordinary income levels, but a slight decline in final profit due to the higher tax burden.
By segment, High Performance Polymers has grown into the core business, generating Revenue of ¥642.3B (+23.9%) and Operating Income of ¥81.0B (+20.9%), with a 12.6% margin, accounting for approximately 57.7% of company-wide Operating Income of ¥140.4B. Materials recorded lower Revenue of ¥502.9B (-2.3%), but Operating Income increased to ¥42.5B (+2.1%), with profitability improving to an 8.4% margin. In contrast, despite higher Revenue of ¥264.9B (+8.2%), Safety’s Operating Income plunged to ¥3.1B (-80.8%), reducing its margin to 1.2% and making it the only segment company-wide to experience deteriorating profitability. Smart contributed with Operating Income of ¥6.7B (+215.5%, 6.2% margin), while Life Sciences contributed Operating Income of ¥5.0B (+138.8%, 10.1% margin); both achieved higher revenue and profit despite their smaller scale. The results indicate that while the shift toward high-performance materials is progressing, deteriorating profitability in Safety is weighing on the company-wide margin.
【Profitability】The Operating Income margin was 9.2%, the Ordinary Income margin was 9.6%, and the Net Income margin (based on income attributable to owners of the parent) was 6.1%. The gross margin was 27.4%, down 1.3pt from 28.7% in the previous year.【Cash Flow Quality】Trade receivables declined 2.9% to ¥1138.8B from ¥1173.1B in the previous year, while inventories increased to ¥1869.9B (¥1745.2B in the previous year, +7.2%), accounting for 21.6% of total assets. Inventory growth of +7.2% was slightly below Revenue growth of +9.4%, indicating no excessive buildup, although the absolute level remains substantial.【Investment Efficiency】Quarterly ROE was 2.5%. The Equity Ratio (based on equity attributable to owners of the parent) was 42.5%, and asset turnover efficiency relative to total assets of ¥8652.9B was limited.【Financial Soundness】The current ratio was 199.3% (current assets of ¥4203.4B/current liabilities of ¥2109.4B). Total interest-bearing debt consisted of long-term borrowings of ¥1709.5B, bonds of ¥700B, short-term borrowings of ¥415.7B, and other items, totaling approximately ¥3107.7B. Compared with cash and deposits of ¥730.3B, the company has secured sufficient short-term repayment capacity.
Although detailed disclosure of the cash flow statement is limited, movements in working capital and funds can be inferred from changes in the balance sheet. Cash and deposits increased to ¥730.3B (¥688.1B in the previous year, +¥42.2B), indicating that cash generation during the period was maintained. Inventories increased to ¥1869.9B (¥1745.2B in the previous year, +¥124.7B), while trade receivables declined to ¥1138.8B (¥1173.1B in the previous year, -¥34.3B), with the movements in the two items largely offsetting each other. Accounts payable increased to ¥704.4B (¥604.5B in the previous year, +16.5%), and trade payables also expanded, suggesting that overall working capital increased naturally in line with business scale expansion. Property, plant and equipment increased to ¥3392.0B (¥3343.6B in the previous year), confirming continued capital investment, including construction in progress of ¥660.5B.
Recurring business activities account for the majority of profit, and dependence on temporary factors is low. Net special gains and losses consisted of a ¥1.5B special gain (gain on sale of investment securities) and a ¥2.7B special loss (loss on disposal of fixed assets), for a net amount of -¥1.2B. This had an impact of less than 1% on Profit Before Tax of ¥144.6B. The net balance between non-operating income of ¥20.9B (including dividends received of ¥3.4B and equity-method investment income of ¥8.8B) and non-operating expenses of ¥15.6B (including interest expense of ¥8.8B and foreign exchange losses of ¥2.1B) boosted Ordinary Income, resulting in Ordinary Income of ¥145.7B exceeding Operating Income of ¥140.4B. After deducting income taxes of ¥49.1B (effective tax rate: 33.9%) and Net Income attributable to non-controlling interests of ¥1.9B from Profit Before Tax of ¥144.6B, Net Income attributable to owners of the parent was ¥93.6B. The approximately 35% gap from Profit Before Tax was primarily attributable to the substantial tax burden. Comprehensive Income was ¥206.2B, substantially exceeding Net Income (¥95.5B for the consolidated group), supported by OCI items including foreign currency translation adjustments of ¥48.4B and valuation differences on available-for-sale securities of ¥61.9B. This gap does not directly reflect the earnings power of the core business, and attention is required because it was significantly affected by external factors such as foreign exchange movements and changes in the market value of held equities.
Progress against the full-year company forecast was 25.6% for Revenue (¥1523.8B/¥5950B), 33.0% for Operating Income (¥140.4B/¥425B), 33.9% for Ordinary Income (¥145.7B/¥430B), and 29.3% for Net Income (¥93.6B/¥320B). Revenue was progressing in line with the standard quarterly pace of 25%, while Operating Income, Ordinary Income, and Net Income were all progressing ahead of the standard pace. Operating Income was particularly front-loaded by approximately +8pt. This appears to have resulted from higher revenue and profit in High Performance Polymers and improvements in non-operating items, suggesting the possibility of progress being weighted toward the first half. Neither the earnings forecast nor the dividend forecast was revised on this occasion, and the full-year plan remains unchanged.
The full-year dividend forecast is ¥70 per share, implying a Payout Ratio of approximately 55.9% against the company’s forecast EPS of ¥125.30. Quarterly EPS was ¥36.65 (¥36.29 in the previous year, +1.0%), representing progress of 29.3% against full-year forecast EPS and aligning with progress in Net Income. With an Equity Ratio of 42.5% and a current ratio of 199.3%, the financial foundation remains stable, consistent with the unchanged dividend forecast.
Deterioration in Safety profitability: Despite Revenue growth to ¥264.9B (+8.2%), Operating Income plunged to ¥3.1B (-80.8%), reducing the margin to 1.2%. The segment’s contribution to company-wide Operating Income of ¥140.4B is minimal, making a recovery in profitability a key focus for company-wide earnings.
Decline in gross margin: The gross margin was 27.4%, down 1.3pt from 28.7% in the previous year. Depending on trends in raw material and energy costs, further downward pressure on margins could arise even amid continued revenue growth.
Inventory buildup: Inventories were ¥1869.9B (¥1745.2B in the previous year, +7.2%), accounting for 21.6% of total assets. If market conditions for high-performance materials fluctuate, the relative risk of inventory write-downs and inventory adjustments is at a comparatively high level.
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 9.2% | 8.8% (4.3%–14.4%) | +0.4pt |
| Net Income Margin | 6.3% | 7.3% (3.3%–10.6%) | -1.0pt |
The Operating Income margin is slightly above the industry median, while the Net Income margin is below the median, indicating somewhat weaker relative efficiency at the final stage of earnings within the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 9.4% | 6.6% (-0.5%–14.7%) | +2.8pt |
The Revenue growth rate exceeds the industry median by +2.8pt, placing the company among the industry’s higher-growth performers.
※Source: Compiled by the Company
The progress rates for Operating Income and Ordinary Income (33.0%, 33.9%) exceed the standard quarterly rate of 25%. The possibility that progress is weighted toward the first half, primarily due to growth in High Performance Polymers, should be considered when evaluating full-year results.
High Performance Polymers has grown into the core business, with Revenue of ¥642.3B (+23.9%) and Operating Income of ¥81.0B (+20.9%), accounting for approximately 57.7% of company-wide Operating Income. This indicates that the center of gravity of the business portfolio is shifting toward high-performance materials.
While the Safety segment’s margin has declined to 1.2%, there is an approximately 35% gap between Ordinary Income and Net Income attributable to the tax burden (effective tax rate: 33.9%). Both segment profitability and the tax burden should be monitored as factors affecting fluctuations in final profit.
This is a reference range mechanically calculated solely from publicly disclosed data using a residual income model (Ohlson-type model with an explicit five-year fade). It is not a forecast of the market share price or a recommendation of any specific investment action.
| Scenario | Theoretical Share Price |
|---|---|
| bear | ¥1,416 |
| base | ¥1,448 |
| bull | ¥1,475 |
| Calculation Assumption | Value |
|---|---|
| Book Value Per Share (BPS) | ¥1,440 |
| Adjusted Forecast EPS | ¥134.7 |
| Cost of Equity r | 9.15% (10-year government bond 2.65% + equity risk premium 6.00% + size premium 0.50%) |
| Persistence Coefficient of Residual Income ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 55.9% |
| Forecast EPS Confidence Adjustment | ×1.075 (based on the industry’s historical guidance achievement rate) |
| Implied PBR / PER |
Sensitivity: ¥1,409–¥1,489 for Cost of Equity ±1%; ¥1,448–¥1,449 for ω±0.1.
Notes:
(Calculation model: Residual income model / Interest rate reference month: 2026-06 / This figure does not forecast or guarantee the future share price)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional advisor as necessary.
---End of Report---
| 1.01x / 10.8x |